Rocket Lab Usa, INC Form 4 insider transactions

NASDAQ
Rocket Lab Corp Director Merline Saintil sold 10,000 shares of common stock at $48 per share on December 4, 2025, under a pre-arranged 10b5-1 plan.
NASDAQ
Rocket Lab Corp's Chief Operations Officer, Frank Klein, sold a portion of his common stock holdings on November 26, 2025, pursuant to a pre-arranged 10b5-1 trading plan.
NASDAQ
Rocket Lab's SVP General Counsel & Secretary, Arjun Kampani, sold 10,554 shares of common stock for approximately $444,130 under a pre-arranged 10b5-1 trading plan.
NASDAQ
Rocket Lab's Chief Financial Officer, Adam C. Spice, sold 62,627 shares of common stock in multiple transactions to cover tax withholding obligations related to restricted stock unit vesting.
NASDAQ
Rocket Lab's Chief Operations Officer, Frank Klein, sold 41,782 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
NASDAQ
Rocket Lab's SVP General Counsel, Arjun Kampani, sold RKLB common stock to cover tax obligations related to restricted stock unit vesting.
NASDAQ
Rocket Lab CEO Peter Beck reported the acquisition of restricted stock units and subsequent planned sales of common stock to cover tax obligations under a 10b5-1 plan.
NASDAQ
Rocket Lab Corp Director Jon A. Olson sold 60,400 shares of common stock for approximately $45.02 per share on November 20, 2025, under a pre-arranged 10b5-1 plan.
NASDAQ
Rocket Lab's Chief Financial Officer, Adam C. Spice, exercised stock options and subsequently sold a portion of the acquired shares to cover taxes and exercise costs.
NASDAQ
Rocket Lab Corp Director Alexander R. Slusky reported a gift of 35,000 common shares to a charitable entity.
NASDAQ
Rocket Lab Director Matthew Ocko reported significant sales and distributions of common stock by affiliated funds, totaling over 1.8 million shares valued at approximately $90 million.
NASDAQ
Rocket Lab's Chief Financial Officer, Adam C. Spice, sold 68,254 shares of common stock on September 16, 2025, primarily to cover tax withholding obligations related to vested restricted stock units.
NASDAQ
Rocket Lab's Chief Operations Officer, Frank Klein, sold a total of 49,812 shares of common stock across two days in September 2025, primarily to cover tax obligations and under a pre-arranged trading plan.
NASDAQ
Rocket Lab's SVP General Counsel & Secretary, Arjun Kampani, reported sales of common stock totaling 40,601 shares in September 2025.
NASDAQ
A trust associated with Rocket Lab's CEO, Peter Beck, and other insiders sold 2.5 million shares of common stock for approximately $127.4 million through a pre-arranged 10b5-1 trading plan.
NASDAQ
Rocket Lab Corp director Nina Armagno received a grant of 3,960 restricted stock units, increasing her beneficial ownership.
NASDAQ
Rocket Lab Corp director Merline Saintil was granted 3,960 restricted stock units as part of her compensation, aligning her interests with shareholders.
NASDAQ
Rocket Lab Director Kenneth R. Possenriede was granted 3,960 restricted stock units as part of his compensation package.
NASDAQ
Rocket Lab Director Jon A. Olson was granted 3,960 restricted stock units as part of his compensation, vesting over the next year.
NASDAQ
Rocket Lab Corp Director Edward H. Frank was granted 3,960 restricted stock units, increasing his beneficial ownership to 150,004 shares.
NASDAQ
Rocket Lab Corp Director Alexander R. Slusky was granted 3,960 restricted stock units, aligning his interests with shareholders.
NASDAQ
Khosla Ventures V, L.P. distributed 3 million shares of Rocket Lab Common Stock pro rata to its partners, including Khosla Ventures Associates V, LLC and VK Services, LLC, for no consideration.
NASDAQ
Khosla Ventures V, L.P. and related entities have completed a pro rata distribution of 2,000,000 Rocket Lab Corp common shares to their partners for no consideration, adjusting beneficial ownership structures.
NASDAQ
Merline Saintil, a Director at Rocket Lab Corp (RKLB), sold a total of 6,353 shares of common stock on June 24, 2025, through a pre-scheduled Rule 10b5-1 trading plan.
NASDAQ
Rocket Lab Corporation Director Merline Saintil has sold 6,353 shares of common stock for approximately $186,000 through a pre-established Rule 10b5-1 trading plan.
NASDAQ
Rocket Lab Corporation Director Matthew Ocko executed sales of over 1 million shares of common stock across two days in June 2025, pursuant to a Rule 10b5-1 trading plan.
NASDAQ
Peter Beck's family trust, Equatorial Trust, has converted 5 million shares of Rocket Lab Series A Preferred Stock into Common Stock, signaling future sales under a pre-arranged 10b5-1 plan.
NASDAQ
Rocket Lab Corporation's Chief Operations Officer, Frank Klein, sold 2,546 shares of common stock for $30 per share on June 9, 2025, as part of a pre-established Rule 10b5-1 trading plan.
NASDAQ
Rocket Lab Corporation's Senior Vice President, General Counsel, and Secretary, Arjun Kampani, sold 5,194 shares of common stock for $30 per share on June 9, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Rocket Lab Corporation's Chief Operations Officer, Frank Klein, reported the sale of 46,703 shares of common stock across two transactions in late May and early June 2025, primarily for tax obligations and under a pre-arranged trading plan.